王国强:全方位发挥中医药防治慢性病作用

2017-09-25 陈计智 中国中医

9月22~23日,全国慢性病防治工作会议在福建省厦门市召开。国家卫生计生委副主任、国家中医药管理局局长王国强在会上强调,要积极贯彻落实中医药法和《“健康中国2030”规划纲要》精神,全方位发挥中医药在慢性病防、治、康、管中的重要作用。

9月22~23日,全国慢性病防治工作会议在福建省厦门市召开。国家卫生计生委副主任、国家中医药管理局局长王国强在会上强调,要积极贯彻落实中医药法和《“健康中国2030”规划纲要》精神,全方位发挥中医药在慢性病防、治、康、管中的重要作用。

王国强指出,“十二五”期间,预防为主、防治结合、中西医并重的防治工作格局正在形成,随着中医中药中国行活动内容不断拓展,全国中医药科普普及率达到84%。群众自觉维护健康的意识显着提高,人人促进健康的社会氛围逐步形成。同时,国家将中医药健康管理等纳入基本公共卫生服务项目,覆盖范围不断扩大,补助标准不断提高,服务规范流程不断完善,居民获得感不断增强,全国近一半65岁以上老年人接受了中医体质辨识和健康干预服务。

为做好当前及今后一段时间的慢性病防治工作,王国强强调,要全方位发挥中医药在慢性病防、治、康、管中的重要作用,以实施中医治未病健康工程为契机,充分发挥中医药在慢性病防治中的优势和作用。深入实施中医治未病健康工程,推动中医医院完善治未病科建设,持续推进中医药健康管理项目落实,扩大目标人群覆盖率,逐步增加慢性病中医药健康管理项目内容。全面实施基层中医药服务能力提升工程“十三五”行动计划,持续扩大基层中医药服务覆盖面,并逐步提升服务质量和内涵。依托基层医疗机构中医综合服务区(国医堂、中医馆),对慢性病人群开展中医医疗保健服务,推广应用中医药防治慢性病的适宜技术和方法,提高慢性病防治效果。加强中医医疗机构各类慢性病、老年病专科建设,落实高血压糖尿病分级诊疗服务中医技术方案,开展中医药慢性病防治研究,针对中医药具有优势的慢性病病种,研究提出中医药防治技术方法。通过中医药健康文化推进行动,加大中医药防治慢性病的科普宣传,引导人们运用中医药的知识、方法改变生活方式,减少慢性病发生的高危因素。

会上,上海市、山东省、福建省厦门市、江苏省镇江市和四川省汶川县的代表进行了有关慢性病防治的经验交流。会议期间,参会人员还对厦门市慢性病综合防治管理模式进行了考察。各省(区、市)卫生计生委和新疆生产建设兵团卫生局分管负责人等出席会议

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1970200, encodeId=f7b619e02009e, content=<a href='/topic/show?id=2f0668266b0' target=_blank style='color:#2F92EE;'>#王国强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68266, encryptionId=2f0668266b0, topicName=王国强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sun Oct 22 22:59:00 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669162, encodeId=b528166916212, content=<a href='/topic/show?id=3ccb215e0b1' target=_blank style='color:#2F92EE;'>#中医药防治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21570, encryptionId=3ccb215e0b1, topicName=中医药防治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e7626506004, createdName=makuansheng, createdTime=Tue May 08 18:59:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264022, encodeId=40801264022fe, content=<a href='/topic/show?id=847353580bf' target=_blank style='color:#2F92EE;'>#慢性病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53580, encryptionId=847353580bf, topicName=慢性病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Wed Sep 27 08:59:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409080, encodeId=e1e314090807f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Sep 27 08:59:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=247662, encodeId=7c4524e662bf, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Sep 25 20:06:30 CST 2017, time=2017-09-25, status=1, ipAttribution=)]
    2017-10-22 wwzzly
  2. [GetPortalCommentsPageByObjectIdResponse(id=1970200, encodeId=f7b619e02009e, content=<a href='/topic/show?id=2f0668266b0' target=_blank style='color:#2F92EE;'>#王国强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68266, encryptionId=2f0668266b0, topicName=王国强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sun Oct 22 22:59:00 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669162, encodeId=b528166916212, content=<a href='/topic/show?id=3ccb215e0b1' target=_blank style='color:#2F92EE;'>#中医药防治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21570, encryptionId=3ccb215e0b1, topicName=中医药防治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e7626506004, createdName=makuansheng, createdTime=Tue May 08 18:59:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264022, encodeId=40801264022fe, content=<a href='/topic/show?id=847353580bf' target=_blank style='color:#2F92EE;'>#慢性病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53580, encryptionId=847353580bf, topicName=慢性病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Wed Sep 27 08:59:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409080, encodeId=e1e314090807f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Sep 27 08:59:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=247662, encodeId=7c4524e662bf, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Sep 25 20:06:30 CST 2017, time=2017-09-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1970200, encodeId=f7b619e02009e, content=<a href='/topic/show?id=2f0668266b0' target=_blank style='color:#2F92EE;'>#王国强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68266, encryptionId=2f0668266b0, topicName=王国强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sun Oct 22 22:59:00 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669162, encodeId=b528166916212, content=<a href='/topic/show?id=3ccb215e0b1' target=_blank style='color:#2F92EE;'>#中医药防治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21570, encryptionId=3ccb215e0b1, topicName=中医药防治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e7626506004, createdName=makuansheng, createdTime=Tue May 08 18:59:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264022, encodeId=40801264022fe, content=<a href='/topic/show?id=847353580bf' target=_blank style='color:#2F92EE;'>#慢性病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53580, encryptionId=847353580bf, topicName=慢性病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Wed Sep 27 08:59:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409080, encodeId=e1e314090807f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Sep 27 08:59:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=247662, encodeId=7c4524e662bf, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Sep 25 20:06:30 CST 2017, time=2017-09-25, status=1, ipAttribution=)]
    2017-09-27 qjddjq
  4. [GetPortalCommentsPageByObjectIdResponse(id=1970200, encodeId=f7b619e02009e, content=<a href='/topic/show?id=2f0668266b0' target=_blank style='color:#2F92EE;'>#王国强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68266, encryptionId=2f0668266b0, topicName=王国强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sun Oct 22 22:59:00 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669162, encodeId=b528166916212, content=<a href='/topic/show?id=3ccb215e0b1' target=_blank style='color:#2F92EE;'>#中医药防治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21570, encryptionId=3ccb215e0b1, topicName=中医药防治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e7626506004, createdName=makuansheng, createdTime=Tue May 08 18:59:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264022, encodeId=40801264022fe, content=<a href='/topic/show?id=847353580bf' target=_blank style='color:#2F92EE;'>#慢性病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53580, encryptionId=847353580bf, topicName=慢性病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Wed Sep 27 08:59:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409080, encodeId=e1e314090807f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Sep 27 08:59:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=247662, encodeId=7c4524e662bf, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Sep 25 20:06:30 CST 2017, time=2017-09-25, status=1, ipAttribution=)]
    2017-09-27 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1970200, encodeId=f7b619e02009e, content=<a href='/topic/show?id=2f0668266b0' target=_blank style='color:#2F92EE;'>#王国强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68266, encryptionId=2f0668266b0, topicName=王国强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sun Oct 22 22:59:00 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669162, encodeId=b528166916212, content=<a href='/topic/show?id=3ccb215e0b1' target=_blank style='color:#2F92EE;'>#中医药防治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21570, encryptionId=3ccb215e0b1, topicName=中医药防治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e7626506004, createdName=makuansheng, createdTime=Tue May 08 18:59:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264022, encodeId=40801264022fe, content=<a href='/topic/show?id=847353580bf' target=_blank style='color:#2F92EE;'>#慢性病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53580, encryptionId=847353580bf, topicName=慢性病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Wed Sep 27 08:59:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409080, encodeId=e1e314090807f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Sep 27 08:59:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=247662, encodeId=7c4524e662bf, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Sep 25 20:06:30 CST 2017, time=2017-09-25, status=1, ipAttribution=)]
    2017-09-25 131****1460

    学习了受益匪浅

    0